Stage IVA Colorectal Cancer Recruiting Phase 1 / 2 Trials for Navitoclax (DB12340)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02079740Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid TumorsTreatment